The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial

Author(s):
Huijbers, A.; Tollenaar, R.A.E.M.; Pelt, G.W. van (0000-0003-1449-7348); Zeestraten, E.C.M.; Dutton, S.; McConkey, C.C.; Domingo, E.; Smit, V.T.H.B.M.; Midgley, R.; Warren, B.F.; Johnstone, E.C.; Kerr, D.J.; Mesker, W.E. (0000-0001-5533-4778)
Published
2013
Publication type
Article / Letter to editor
ASCOcolon cancerpathologyprognosticstromaVICTOR
Date issued
2013-01-31
Language
English
Is part of
Annals of Oncology (2013), Vol. 24, no. 1, p. 179-185
hdl
1887/113988
doi
10.1093/annonc/mds246